Keith Speights
TMFFishBiz
Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights

Jul 3, 2025
by Keith Speights
What Is a PDUFA Date?

Jun 30, 2025
by Keith Speights
3 Stocks I Plan to Hold for the Next 20 Years

Jun 30, 2025
by Keith Speights
3 Red-Hot Growth Stocks to Buy in 2025

Jun 30, 2025
by Keith Speights
Could Buying IonQ Stock Set You Up for Life?

Jun 29, 2025
by Keith Speights
3 Dividend Stocks to Double Up on Right Now

Jun 28, 2025
by Keith Speights
Got $500? 2 Healthcare Stocks to Buy and Hold Forever

Jun 27, 2025
by Keith Speights
2 Tech Stocks You Can Buy and Hold for the Next Decade

Jun 24, 2025
by Keith Speights
Most Volatile Stocks in 2025
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.